Correlation Between SSAB AB and Vicore Pharma

Can any of the company-specific risk be diversified away by investing in both SSAB AB and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SSAB AB and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SSAB AB and Vicore Pharma Holding, you can compare the effects of market volatilities on SSAB AB and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SSAB AB with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of SSAB AB and Vicore Pharma.

Diversification Opportunities for SSAB AB and Vicore Pharma

-0.75

Correlation Coefficient

SSAB AB  Vicore Pharma

Pay attention - limited upside

The 3 months correlation between SSAB and Vicore is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding SSAB AB and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and SSAB AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SSAB AB are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of SSAB AB i.e., SSAB AB and Vicore Pharma go up and down completely randomly.

Pair Corralation between SSAB AB and Vicore Pharma

Assuming the 90 days trading horizon SSAB AB is expected to generate 0.83 times more return on investment than Vicore Pharma. However, SSAB AB is 1.2 times less risky than Vicore Pharma. It trades about 0.24 of its potential returns per unit of risk. Vicore Pharma Holding is currently generating about -0.07 per unit of risk. If you would invest  4,391  in SSAB AB on December 30, 2024 and sell it today you would earn a total of  1,871  from holding SSAB AB or generate 42.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

SSAB AB  vs.  Vicore Pharma Holding

SSAB AB

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in SSAB AB are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, SSAB AB sustained solid returns over the last few months and may actually be approaching a breakup point.

Vicore Pharma Holding

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vicore Pharma Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with SSAB AB and Vicore Pharma

The main advantage of trading using opposite SSAB AB and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SSAB AB position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.

The idea behind SSAB AB and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.